Abstract
Gliomas, the most common form of intrinsic brain tumor, are characterized by diffuse local invasion of the normal brain structures, irrespective of their histological grade of malignancy; a feature that is a major obstacle to successful therapy. They generally infiltrate the central nervous system (CNS) as individual tumor cells several centimeters beyond the macroscopic tumor margin and consequently often recur, after subtotal surgical resection. Factors involved in the control of both their proliferation and invasiveness are poorly documented. In this work, the role of gangliosides on proliferation of both human fetal human brain cells and five cell lines derived from human gliomas with different grades of malignancy was investigated. In addition, 8 μm-porosity polycarbonate filters were used to study cell motility. In addition, these filters were coated with the reconstituted extracellular matrix (ECM) composite, Matrigel, to assess invasiveness. The results presented show that gangliosides generally exert a proliferation inhibitory effect on fetal brain cells and glioma cell lines in vitro and play an important role in promoting glioma cell motility and invasiveness. The molecular mechanisms involved in the action of gangliosides may prove useful in identifying new targets for an anti-invasion therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albini A., Iwamoto Y., Kleinman H. K., Martin G. R., Aaronson S. A., Kozlowski J. M., and McEwan R. N. (1987) A rapid in vitro assay for quantitating the invasive potential of tumour cells.Cancer Res. 47, 3239–3245.
Bogler O., Wren D., Barnett S., Land H., and Noble M. (1990) Cooperation between two growth factors promotes extended self renewal and inhibits differentiation of 02-A progrenitor cells.Proc. Natl. Acad. Sci. USA 87, 6368–6372.
Burger P. C., Vogel F. S., Green S. B., and Strike T. A. (1985) Glioblastoma multiforme and anaplastic astrocytoma: pathological criteria and prognostic implications.Cancer 56, 1106–1111.
Cheresh D. A., Pierschbacher M. D., Herzig M. A., and Mujoo K. (1987) Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.J. Cell Biol. 105, 1163–1173.
Fishman P. H. and Brady R. O. (1976) Biosynthesis and function of gangliosides.Science 194, 906–915.
Frame M. C., Freshney R. I., Vaughan P. F., Graham, D. I., and Shaw R. (1984) Interrelationship between differentiation and malignancy-associated properties in glioma.Brit. J. Cancer 49, 269–280.
Fredman P., Magnani G. L., Nirenberg M., and Ginsberg V. (1984) Monoclonal antibody A2B5 reacts with many gangliosides in neuronal tissue.Arch. Biochem. Biophys. 233, 661–666.
Hakomori S. I. (1981) Glycosphingolipids in cellular interaction, differentiation and oncogenesis.Annu. Rev. Biochem. 50, 733–764.
Hakomori S. I. (1990) Bifunctional role of glycosphingolipids.J. Biol. Chem. 265, 18713–18716.
Hamilton W. B., Helling F., Lloyd K. O., and Livingston P. O. (1993) Ganglioside expression of human malignant melanoma assessed by quantitative immune thin-layer chromatography.Int. J. Cancer 53, 566–573.
Iwasaki K., Rogers L. R., Barnett G. H., Estes M. L., and Barna B. P. (1993) Effect of recombinant tumour necrosis factor-α on three dimensional growth, morphology, and invasiveness of human glioblastoma cells in vitro.J. Neurosurg. 78, 952–958.
Knott J. C. A., Edwards A. J., Gullan R. W., Clarke T. M., and Pilkington G. J. (1990) A human glioma cell line retaining expression of GFAP and gangliosides, recognized by A2B5 and LB1 antibodies, after prolonged passage.Neuropathol. Appl. Neurobiol. 16, 489–500.
Koochekpour S., Merzak A., and Pilkington G. J. (1995) Growth factors and gangliosides stimulate laminin production by human glioma cells in vitro.Neurosc. Letts. 186, 53–56.
Kundu S., Pleetman M., Redwine W., Boyd A., and Marcus D. (1983) Binding of monoclonal antibody A2B5 to gangliosides.Biochem. Biophys. Res. Commun. 116, 836–842.
Liepkalns V. A., Burtin M. C., Correc P., Durand H., and Maunroy M. T. (1990) Ganglioside inhibition of (125I)-plasmin binding to colorectal carcinoma cells.J. Recep. Res. 10, 333–351.
Maidment S., Merzak A., Koochekpour S., Rooprai H., and Pilkington G. J. (1995) Secretion of metalloproteases by human brain tumours cell lines in vitro: modulation by exogenous gangliosides.J. Neuro. Oncol. in press.
Merzak A., McCrea S., Koochekpour S., and Pilkington G. J. (1994a) Control of human glioma cell growth, migration, and invasion in vitro by transforming growth factor-beta1.Br. J. Cancer 70, 199–203.
Merzak A., Koochekpour S., and Pilkington G. J. (1994b) CD44 mediates human glioma cell adhesion and invasion in vitro.Cancer Res 54, 3988–3992.
Merzak A., Koochekpour S., and Pilkington G. J. (1994c) Cell surface gangliosides are involved in the control of human glioma cell invasion in vitro.Neurosci. Letts. 177, 44–46.
Merzak A., Parker C., Koochekpour C., Sherbet G., and Pilkington G. J. (1994d) Overexpression of the 18A2/mts1 gene and down regulation of the TIMP-2 gene in invasive human glioma cell lines in vitro.Neuropath. Appl. Neurobiol. 20, 614–619.
Merzak A., Koochekpour S., and Pilkington G. J. (1995) Adhesion of human glioma cell lines to fibronectin, laminin, vitronectin, and collagen I is modulated by gangliosides in vitro.Cell Adhesion and Communication, in press.
Miles L. A., Dahlberg C. M., Levin E. G., and Plow E. F. (1989) Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells.Biochemistry 28, 9337–9343.
Mugnai G., Lewandowska K., Choi H. U., Rosenberg L. C., and Culp L. A. (1988) Ganglioside-dependent adhesion events of human neuroblastoma cells regulated by the RGDS-dependent fibronectin receptor and proteoglycans.Exp. Cell Res. 175, 229–247.
Pilkington G. J. (1992) Glioma heterogeneity in vitro: the significance of growth factors and gangliosides.Neuropath. Appl. Neurobiol. 18, 434–442.
Russell D. S. and Rubinstein L. J. (1989)Pathology of Tumours of the Nervous System, pp. 83–289. Williams & Wilkins, Baltimore, MD.
Salcman M. (1980) Survival in glioblastoma: historical perspective.Neurosurgery 7, 435–439.
Shepherd G. M. (1983) Neurobiology, pp. 164–183. Oxford University, New York, Oxford.
Small R. K., Riddle P., and Noble M. (1987) Evidence for migration of oligodendrocyte-type 2 astrocyte progenitor cells into developing rat optic nerve.Nature 328, 155–157.
Stallcup W. B. (1988) Involvement of gangliosides and glycoprotein fibronectin receptors in cellular adhesion to fibronectin.Exp. Cell. Res. 177, 90–102.
Thompson L. K., Horowitz P. M., Bentley K. L., Thomas D. D., Alderete J. F., and Klebe R. J. (1986) Localization of the ganglioside-binding site of fibronectin.J. Biol. Chem. 261, 5209–5214.
Van Brocklyn J., Bremer E. G., and Yates A. J. (1993) Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 cells.J. Neurochem. 61, 371–374.
Yates A. J., Van Brocklyn J., Saqr H. E., Guan Z., Stokes B. T., and O’Dorisio M. S. (1993) Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium, and receptor binding.Exp. Cell Res. 204, 38–45.
Yavin E., Gabai A., and Gil S. (1991) Nerve growth factor mediates monosialoganglioside-induced release of fibronectin and J1/tenascin from C6 glioma cells.J. Neurochem. 56, 105–112.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Merzak, A., Koochekpour, S., McCrea, S. et al. Gangliosides modulate proliferation, migration, and invasiveness of human brain tumor cells in vitro. Molecular and Chemical Neuropathology 24, 121–135 (1995). https://doi.org/10.1007/BF02962138
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02962138